Weight Loss News and Research

Latest Weight Loss News and Research

Vicus initiates VT-122 Phase 2 trial in advanced liver cancer, systemic inflammation and cachexia

Vicus Therapeutics, LLC, today announced the initiation of a Phase 2 trial evaluating VT-122, a novel investigational combination of etodolac and propranolol, and Nexavar® (sorafenib) tablets, as a potential new treatment option for patients with advanced liver cancer (hepatocellular carcinoma), systemic inflammation and cachexia.

28 Dec 2010

New findings may solve mystery about how starvation hormone affects multiple biological systems

New findings by UT Southwestern Medical Center researchers may solve a 17-year-old mystery about how the so-called "starvation hormone" affects multiple biological systems, including preventing insulin sensitivity and promoting cell survival.

27 Dec 2010

Pros and cons of apps for common New Year's resolutions

With about 400,000 apps available for Smartphones and news ones added daily, there is an app for almost everything, from losing weight to finding a job.

24 Dec 2010

Dieting trends in 2011

As the hectic holiday season comes to a close and a new year approaches, many consumers are once again vowing to adopt weight loss goals to shed those unwanted pounds. But with obesity increasing at alarming levels across the globe, a number of health experts are urging a new approach to help fight the nation's burgeoning weight problem.

23 Dec 2010

Key to long-term weight-loss success is finding unique individual level of carbohydrate tolerance

Recent media coverage suggests that the reported wedding diet of Carole Middleton, mother of future British princess Kate Middleton, is something brand new. Yet the Dukan Diet is just another variation of the Atkins Diet™, but with some nutritional recommendations that simply don't make sense or are guaranteed to fail.

23 Dec 2010

Amylin, Lilly submit BYETTA sNDA for type 2 diabetes

Amylin Pharmaceuticals, Inc. and Eli Lilly and Company today announced that a supplemental New Drug Application (sNDA) has been submitted to the U.S. Food and Drug Administration (FDA) for the expanded use of BYETTA® (exenatide) injection as an add-on therapy to basal insulin, with or without metformin and/or a thiazolidinedione (TZD) in conjunction with diet and exercise for adults with type 2 diabetes who are not achieving adequate glycemic control.

23 Dec 2010

Arena, Eisai complete lorcaserin NDA end-of-review meeting with FDA

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today the completion of an end-of-review meeting with the US Food and Drug Administration (FDA) for the lorcaserin New Drug Application (NDA).

22 Dec 2010

Excessive carbohydrates, rather than fat, may be the source of America's dietary woes

A growing number of top nutritional scientists are pointing to excessive carbohydrates, rather than fat, as the source of America's dietary woes. As reported in the Los Angeles Times on December 20, some researchers are saying that cutting carbohydrates is the key to reversing obesity, heart disease, Type 2 diabetes and hypertension.

22 Dec 2010

Writing habit 'is one of the top predictors of weight loss success'

The first step to reaching your ideal weight in the New Year may be as simple as writing it down.

21 Dec 2010

Gastric bypass surgeries performed using da Vinci Surgical System

Friday, bariatric surgeons at St. Vincent's East, Lee Schmitt, M.D., F.A.C.S. and Robert (Les) Miles, M.D., F.A.C.S., of Alabama Weight Loss Surgery, performed two gastric bypass surgeries using the da Vinci® Surgical System, also known as the "robot." Dr. Schmitt and Dr. Miles will be the only bariatric surgeons in the state of Alabama routinely offering patients this minimally invasive option in gastric bypass surgery.

21 Dec 2010

Positive results from Incyte's COMFORT-I INCB18424 pivotal Phase III clinical trial in myelofibrosis

Incyte Corporation announced today positive top-line results from COMFORT-I, the pivotal Phase III clinical trial of INCB18424 (also known as INC424) in patients with myelofibrosis (MF) being conducted under a Food and Drug Administration (FDA) Special Protocol Assessment (SPA) Agreement. COMFORT-I (COntrolled MyeloFibrosis Study with ORal JAK Inhibitor Treatment) is a double-blind, placebo-controlled Phase III trial involving 309 patients.

21 Dec 2010

Hutchinson Center's tips for weight loss in the new year

Losing weight is at the top of many a New Year's resolution list. In addition to maintaining a healthy diet and getting enough exercise, what else can one do to make sure those good intentions have a lasting impact throughout the year?

21 Dec 2010

Arrowhead launches new company, Ablaris to commercialize novel weight loss technology

Arrowhead Research Corporation today announced that it has executed an exclusive world-wide license on technology developed by Drs. Wadih Arap and Renata Pasqualini at MD Anderson Cancer Center for use in weight loss and obesity-related metabolic conditions, and that it has launched a new company, Ablaris Therapeutics Inc., to commercialize this platform.

20 Dec 2010

VIVUS seeks marketing approval of QNEXA in the EU

VIVUS, Inc. today announced that the company filed a Marketing Authorization Application (MAA) with the European Medicines Agency (EMA) for QNEXA® (phentermine/topiramate) Controlled Release Capsules in the European Union (EU). The proposed indication in the EU is for the treatment of obesity, including weight loss and maintenance of weight loss, and should be used in conjunction with a mildly hypocaloric diet.

20 Dec 2010

Nation's leading health care systems collaborate to improve quality while reducing costs

Six of the nation's leading health care systems today announced a first-of-its-kind collaboration to improve health care quality while reducing costs.

16 Dec 2010

Study links large waistline to increased risk of heart problems and type 2 diabetes

Researchers at Eastern Virginia Medical School’s Strelitz Diabetes Center and the school’s department of physiological sciences have published research showing a strong link between a large waistline and increased risk of Type 2 diabetes and cardiovascular disease.

14 Dec 2010

VIVUS submits briefing document to FDA in effort to secure regulatory approval for QNEXA

VIVUS, Inc. today announced that the company, as part of its continuing effort to secure regulatory approval for QNEXA® in the U.S., submitted a briefing document to the Food and Drug Administration (FDA) designed to address items in the FDA's Complete Response Letter (CRL), issued on October 28, 2010. The company also announced that the Endocrine and Metabolic Division of the FDA has granted VIVUS a meeting in the second half of January 2011 to discuss the content of the proposed resubmission.

14 Dec 2010

Clinical trial investigates pomalidomide in only U.S. study for multiple myeloma

Multiple myeloma, a type of blood cancer in which malignant plasma cells are overproduced in the bone marrow, has led to an estimated 20,000 new diagnoses and 11,000 deaths in 2010. Patients with the disease, who have already failed previous treatments, may be considered for a currently enrolling Phase II study, examining a unique drug combination.

14 Dec 2010

With The CarbLovers Diet, eating carbohydrates foods is the only way to lose weight

Who would have thought you could eat your favorite carbohydrate-rich foods and still lose weight? If your New Year's resolution is to lose weight in 2011, Health's bestselling book, The CarbLovers Diet by Ellen Kunes (Editor-in-Chief, Health) and Frances Largeman-Roth, RD (Senior Food & Nutrition Editor, Health), may be the solution.

14 Dec 2010

Soda taxes – would they do any good?

According to new research from Duke-National University of Singapore (NUS) Graduate Medical School imposing higher taxes on sodas and other sweetened drinks would lead to only minimal weight loss among most people and would have no effect on weight among consumers in the highest and lowest income groups.

13 Dec 2010

Weight Loss News and Research

Latest Weight Loss News and Research

Vicus initiates VT-122 Phase 2 trial in advanced liver cancer, systemic inflammation and cachexia

New findings may solve mystery about how starvation hormone affects multiple biological systems

Pros and cons of apps for common New Year's resolutions

Dieting trends in 2011

Key to long-term weight-loss success is finding unique individual level of carbohydrate tolerance

Amylin, Lilly submit BYETTA sNDA for type 2 diabetes

Arena, Eisai complete lorcaserin NDA end-of-review meeting with FDA

Excessive carbohydrates, rather than fat, may be the source of America's dietary woes

Writing habit 'is one of the top predictors of weight loss success'

Gastric bypass surgeries performed using da Vinci Surgical System

Positive results from Incyte's COMFORT-I INCB18424 pivotal Phase III clinical trial in myelofibrosis

Hutchinson Center's tips for weight loss in the new year

Arrowhead launches new company, Ablaris to commercialize novel weight loss technology

VIVUS seeks marketing approval of QNEXA in the EU

Nation's leading health care systems collaborate to improve quality while reducing costs

Study links large waistline to increased risk of heart problems and type 2 diabetes

VIVUS submits briefing document to FDA in effort to secure regulatory approval for QNEXA

Clinical trial investigates pomalidomide in only U.S. study for multiple myeloma

With The CarbLovers Diet, eating carbohydrates foods is the only way to lose weight

Soda taxes – would they do any good?

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Weight Loss News and Research

Latest Weight Loss News and Research

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Newsletters you may be interested in